Related Experiment Videos
[Type I multiple endocrine neoplasia--Wermer syndrome]
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|August 29, 1989
Summary
Multiple endocrine neoplasia type 1 (MEN1), or Wermer's syndrome, involves tumors of the pancreas, pituitary, and parathyroids. Diagnosis requires specific tests, while treatment may involve medication or surgery.
Area of Science:
- Endocrinology
- Genetics
- Oncology
Context:
- Multiple endocrine neoplasia (MEN) syndromes are inherited disorders characterized by tumors in specific endocrine glands.
- Wermer's syndrome (MEN1) specifically affects the endocrine pancreas, anterior pituitary, and parathyroid glands.
Purpose:
- To outline diagnostic approaches for Wermer's syndrome.
- To detail diagnostic criteria and localization techniques for endocrine tumors associated with MEN1.
- To discuss management strategies for MEN1-related conditions.
Summary:
- Wermer's syndrome (MEN1) is a genetic disorder affecting the endocrine pancreas (most commonly insulinoma), anterior pituitary, and parathyroids.
- Diagnostic tools include prolonged oral glucose tolerance tests, fasting tests, glucose-insulin ratios, CT scans, and angiography.
- Gastrinomas are ruled out by normal gastrin levels and secretin tests; pituitary tumors are classified using hormone levels and releasing hormone tests. Primary hyperparathyroidism is excluded via calcium and parathormone levels, with chief cell hyperplasia or adenomas being common, often requiring surgical intervention.
Impact:
- Facilitates accurate diagnosis and timely management of Wermer's syndrome.
- Improves patient outcomes through targeted diagnostic and therapeutic strategies.
- Contributes to the understanding of genetic endocrine tumor syndromes and their clinical manifestations.